Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Bacteria on Skin Boost Immune Cell Function

Published: Friday, August 17, 2012
Last Updated: Friday, August 17, 2012
Bookmark and Share
The findings provides new insights into skin health.

The harmless bacteria that thrive on the skin can help immune cells fight disease-causing microbes, according to a new study in mice.

Skin is a barrier that's one of the first lines of defense against harmful microbes. Specialized immune cells within skin tissue also help to fight invading organisms.

The skin's surface is home to surprisingly diverse communities of bacteria, collectively known as the skin microbiota.

Past research suggested that these bacteria might play a role in skin health and immune responses, but the details have been unclear.

In the new study, scientists took a closer look at how skin microbiota might influence immune cell function.

The team was led by Dr. Yasmine Belkaid of NIH's National Institute of Allergy and Infectious Diseases (NIAID), with colleagues at NIH's National Human Genome Research Institute (NHGRI) and National Cancer Institute (NCI). Their report appeared in the early online edition of Science on July 26, 2012.

The scientists worked with special germ-free mice, born and raised with no naturally occurring microbes on the skin or in the gut. These mice, the researchers found, had weakened skin immune function compared to normal mice, which have vibrant bacterial communities on their skin.

The skin tissue of normal mice contained a variety of immune cells known as T cells and diverse immune signaling molecules.

Germ-free mice, in contrast, had significantly lower levels of certain signaling molecules and unusually high levels of a type of T cell that suppresses immune function.

In separate experiments, the researchers found that the presence or absence of microbes in the gut seemed to have no effect on the skin's immune responses. This finding suggests that bacteria have unique roles at different sites in the body.

The investigators next colonized the germ-free mice with Staphylococcus epidermidis, one of the most common bacteria on human skin.

Adding this one species of bacteria triggered an immune response in the skin and led to production of cell-signaling molecules that help to combat harmful microbes.

The researchers then infected germ-free mice with the skin parasite Leishmania major. At the same time, some mice were also exposed to S. epidermidis, which colonized their skin. These colonized mice mounted an effective immune response to the parasite; the bacteria-free mice did not.

“We often have a sense that the bacteria that live on our skin are harmful,” says study co-author Dr. Julie Segre of NHGRI. “But in this study we show that these bacteria can play an important role in promoting health by preventing skin infections from becoming more prolonged, pronounced and more serious.”

“Certain inflammatory disorders of the skin have been linked to a change in the nature of the bacteria that we have on the skin, but the relationship between this change and disease was not clear,” Belkaid says.

Belkaid continued, “Our findings provide a mechanistic link showing how these bacteria can manipulate immune responses and inflammation. What remains to be done-and what we are doing in collaboration with clinicians at NIH-is to see how relevant our findings in mice might be when applied to humans.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

In Uveitis, Bacteria in Gut May Instruct Immune Cells to Attack the Eye
NIH scientists propose novel mechanism to explain autoimmune uveitis.
Wednesday, August 19, 2015
Novel Mechanism to Explain Autoimmune Uveitis Proposed
A new study on mice suggests that bacteria in the gut may provide a kind of training ground for immune cells to attack the eye.
Wednesday, August 19, 2015
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Tuesday, July 21, 2015
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Thursday, May 28, 2015
For Most Children with HIV and Low Immune Cell Count, Cells Rebound After Treatment
NIH-funded study finds T-cell level returns to normal with time.
Saturday, March 28, 2015
Strengthening the Immune System’s Fight Against Brain Cancer
NIH-funded research suggests novel way to improve vaccine efficacy in brain tumors.
Friday, March 20, 2015
Autoimmune Disease Super-Regulators Uncovered
Scientists discovered key genetic switches, called super-enhancers, involved in regulating the human immune system.
Tuesday, March 17, 2015
NIH Announces $41.5 Million in Funding for the Human Placenta Project
Better understanding of the placenta promises to improve the health of mothers and children.
Tuesday, March 03, 2015
NIH-funded Scientists Create Potential Long-acting HIV Therapeutic
New molecule also might prevent HIV infection.
Tuesday, February 24, 2015
Link Between Powerful Gene Regulatory Elements and Autoimmune Diseases Revealed
Findings point to potential drug targets.
Thursday, February 19, 2015
NIH-Sponsored HIV Vaccine Trial Launches In South Africa
Early-stage trial aims to build on RV144 results.
Thursday, February 19, 2015
Stem Cell Transplants May Halt Progression of Multiple Sclerosis
NIH-funded study yields encouraging early results.
Tuesday, December 30, 2014
Candidate H7N9 Avian Flu Vaccine Works Better With Adjuvant
Results of large NIH-sponsored trial demonstrate improved vaccine response when an adjuvant was used.
Wednesday, October 08, 2014
NIH Awards Seven New Vaccine Adjuvant Discovery Contracts
Total funding for these contracts reach approximately $70 million over five years.
Tuesday, October 07, 2014
NIH to Admit Patient Exposed to Ebola Virus for Observation
Ebola patients can be safely cared for at any hospital that follows CDC's infection control recommendations.
Wednesday, October 01, 2014
Scientific News
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Four Gut Bacteria Decrease Asthma Risk in Infants
New research by scientists at UBC and BC Children’s Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos